Circulating Extracellular DNA: Cause or Consequence of Thrombosis?

Seminars in Thrombosis and Hemostasis

Volumn 43, Issue 6, 2017, Pages 553-561

  Jiménez Alcázar, Miguel ^a   Kim, Natalie ^a   Fuchs, Tobias A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

biomarker; cell free DNA; extracellular DNA; neutrophil extracellular traps; plasma DNA; thrombosis

Indexed keywords

DNA; BIOLOGICAL MARKER;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONGENITAL HEART DISEASE; DISSEMINATED INTRAVASCULAR CLOTTING; EXTRACELLULAR TRAP; HEART FAILURE; HEART INFARCTION; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VENOUS THROMBOEMBOLISM; BLOOD; METABOLISM;

BIOMARKERS; DNA; EXTRACELLULAR TRAPS; HUMANS; MYOCARDIAL INFARCTION; THROMBOSIS;

EID: 85016272084     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0036-1597284     Document Type: Article

References (111)

1. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost: 2014; 12 10 1580 1590
2. Kelly B. B. Narula J. Fuster V. Recognizing global burden of cardiovascular disease and related chronic diseases. Mt Sinai J Med: 2012; 79 06 632 640
3. Martinod K. Wagner D. D. Thrombosis: tangled up in NETs. Blood: 2014; 123 18 2768 2776
4. Kimball A. S. Obi A. T. Diaz J. A. Henke P. K. The emerging role of NETs in venous thrombosis and immunothrombosis. Front Immunol: 2016; 7 236
5. Engelmann B. Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol: 2013; 13 01 34 45
6. Cerletti C. Tamburrelli C. Izzi B. Gianfagna F. de Gaetano G. Platelet-leukocyte interactions in thrombosis. Thromb Res: 2012; 129 03 263 266
7. Kushnir M. Cohen H. W. Billett H. H. Persistent neutrophilia is a marker for an increased risk of venous thrombosis. J Thromb Thrombolysis: 2016; 42 04 545 551
8. von Brühl M. L. Stark K. Steinhart A., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med: 2012; 209 04 819 835
9. Massberg S. Grahl L. von Bruehl M. L., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med: 2010; 16 08 887 896
10. Brinkmann V. Reichard U. Goosmann C., et al. Neutrophil extracellular traps kill bacteria. Science: 2004; 303 (5663): 1532 1535
11. Fuchs T. A. Abed U. Goosmann C., et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol: 2007; 176 02 231 241
12. Wang Y. Li M. Stadler S., et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol: 2009; 184 02 205 213
13. Li P. Li M. Lindberg M. R. Kennett M. J. Xiong N. Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med: 2010; 207 09 1853 1862
14. Semeraro F. Ammollo C. T. Morrissey J. H., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood: 2011; 118 07 1952 1961
15. Fuchs T. A. Bhandari A. A. Wagner D. D. Histones induce rapid and profound thrombocytopenia in mice. Blood: 2011; 118 13 3708 3714
16. Kambas K. Chrysanthopoulou A. Vassilopoulos D., et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis: 2014; 73 10 1854 1863
17. Oklu R. Albadawi H. Watkins M. T. Monestier M. Sillesen M. Wicky S. Detection of extracellular genomic DNA scaffold in human thrombus: implications for the use of deoxyribonuclease enzymes in thrombolysis. J Vasc Interv Radiol: 2012; 23 05 712 718
18. Savchenko A. S. Martinod K. Seidman M. A., et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost: 2014; 12 06 860 870
19. Nakazawa D. Tomaru U. Yamamoto C. Jodo S. Ishizu A. Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol: 2012; 3 333
20. Mangold A. Alias S. Scherz T., et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res: 2015; 116 07 1182 1192
21. de Boer O. J. Li X. Teeling P., et al. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost: 2013; 109 02 290 297
22. Megens R. TA. Vijayan S. Lievens D., et al. Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb Haemost: 2012; 107 03 597 598
23. Brill A. Fuchs T. A. Savchenko A. S., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost: 2012; 10 01 136 144
24. Savchenko A. S. Borissoff J. I. Martinod K., et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood: 2014; 123 01 141 148
25. De Meyer S. F. Suidan G. L. Fuchs T. A. Monestier M. Wagner D. D. Extracellular chromatin is an important mediator of ischemic stroke in mice. Arterioscler Thromb Vasc Biol: 2012; 32 08 1884 1891
26. Martinod K. Demers M. Fuchs T. A., et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A: 2013; 110 21 8674 8679
27. Masuda S. Nakazawa D. Shida H., et al. NETosis markers: quest for specific, objective, and quantitative markers. Clin Chim Acta: 2016; 459 89 93
28. Fuchs T. A. Brill A. Duerschmied D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A: 2010; 107 36 15880 15885
29. Chiu R. W. Chan L. Y. Lam N. Y., et al. Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem: 2003; 49 05 719 726
30. van der Vaart M. Pretorius P. J. The origin of circulating free DNA. Clin Chem: 2007; 53 12 2215
31. von Köckritz-Blickwede M. Goldmann O. Thulin P., et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood: 2008; 111 06 3070 3080
32. Yousefi S. Gold J. A. Andina N., et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med: 2008; 14 09 949 953
33. Yousefi S. Simon D. Simon H. U. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr Opin Immunol: 2012; 24 06 736 739
34. Chow O. A. von Köckritz-Blickwede M. Bright A. T., et al. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe: 2010; 8 05 445 454
35. Li S. K. Leung R. K. Guo H. X., et al. Detection and identification of plasma bacterial and viral elements in HIV/AIDS patients in comparison to healthy adults. Clin Microbiol Infect: 2012; 18 11 1126 1133
36. Dinakaran V. Rathinavel A. Pushpanathan M. Sivakumar R. Gunasekaran P. Rajendhran J. Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation. PLoS One: 2014; 9 08 e105221
37. Tamkovich S. N. Bryzgunova O. E. Rykova E. Y. Permyakova V. I. Vlassov V. V. Laktionov P. P. Circulating nucleic acids in blood of healthy male and female donors. Clin Chem: 2005; 51 07 1317 1319
38. Suzuki N. Kamataki A. Yamaki J. Homma Y. Characterization of circulating DNA in healthy human plasma. Clin Chim Acta: 2008; 387 (1-2): 55 58
39. Leon S. A. Shapiro B. Sklaroff D. M. Yaros M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res: 1977; 37 03 646 650
40. Diehl F. Schmidt K. Choti M. A., et al. Circulating mutant DNA to assess tumor dynamics. Nat Med: 2008; 14 09 985 990
41. Newman A. M. Bratman S. V. To J., et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med: 2014; 20 05 548 554
42. Li J. Z. Steinman C. R. Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. Arthritis Rheum: 1989; 32 06 726 733
43. Lo Y. M. Rainer T. H. Chan L. Y. Hjelm N. M. Cocks R. A. Plasma DNA as a prognostic marker in trauma patients. Clin Chem: 2000; 46 03 319 323
44. Martins G. A. Kawamura M. T. Carvalho MdaG. Detection of DNA in the plasma of septic patients. Ann N Y Acad Sci: 2000; 906 134 140
45. Nakahira K. Kyung S. Y. Rogers A. J., et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med: 2013; 10 12 e1001577, discussion e1001577
46. Heit J. A. Epidemiology of venous thromboembolism. Nat Rev Cardiol: 2015; 12 08 464 474
47. Jaff M. R. McMurtry M. S. Archer S. L., et al. American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation: 2011; 123 16 1788 1830
48. Davis G. L. Jr. Davis J. S. IV. Detection of circulating DNA by counterimmunoelectrophoresis (CIE). Arthritis Rheum: 1973; 16 01 52 58
49. Nowotny A. Counter immunoelectrophoresis. In: Basic Exercises in Immunochemistry: A Laboratory Manual. Berlin, Heidelberg Springer: 1979; 243 245
50. Sipes J. N. Suratt P. M. Teates C. D. Barada F. A. Davis J. S. Tegtmeyer C. J. A prospective study of plasma DNA in the diagnosis of pulmonary embolism. Am Rev Respir Dis: 1978; 118 03 475 478
51. Barada F. A. Jr. Suratt P. M. Davis J. S. IV., et al. Free plasma DNA in patients with pulmonary embolism. South Med J: 1980; 73 03 345 346, 350
52. Riboldi P. Asero R. Marazzini L., et al. Detection of circulating DNA in plasma of patients with pulmonary embolism by counterimmunoelectrophoresis. Respiration: 1984; 45 01 45 49
53. Vargo J. S. Becker D. M. Philbrick J. T. Schoonover F. W. Davis J. S. Plasma DNA. A simple, rapid test for aiding the diagnosis of pulmonary embolism. Chest: 1990; 97 01 63 68
54. Davis J. S. IV. Suratt P. M. Plasma and serum concentrations of DNA in pulmonary thromboembolism. Am Rev Respir Dis: 1982; 126 05 940 941
55. Lippmann M. L. Morgan L. Fein A. Shapiro B. Leon S. A. Plasma and serum concentrations of DNA in pulmonary thromboembolism. Am Rev Respir Dis: 1982; 125 04 416 419
56. Goldhaber S. Z. Hennekens C. H. Markisz J. A., et al. Low sensitivity of plasma DNA in screening for pulmonary embolism. Am Rev Respir Dis: 1982; 126 02 360 361
57. Breitwieser W. R. Hartman C. W. Morris W. S. Fleetwood M. K. Baxter J. A. Albertini R. E. Plasma DNA in the diagnosis of pulmonary embolism. Thorax: 1983; 38 03 209 211
58. Cooper T. J. Prothero D. L. Gillett M. G., et al. Laboratory investigation in the diagnosis of pulmonary thromboembolism. Q J Med: 1992; 83 301 369 379
59. Arnalich F. Maldifassi M. C. Ciria E., et al. Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study. Crit Care: 2013; 17 03 R90
60. van Montfoort M. L. Stephan F. Lauw M. N., et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol: 2013; 33 01 147 151
61. Diaz J. A. Fuchs T. A. Jackson T. O., et al. for the Michigan Research Venous Group. Plasma DNA is elevated in patients with deep vein thrombosis. J Vasc Surg Venous Lymphat Disord: 2013; 1(4)
62. Chang C. P-Y. Chia R-H. Wu T-L. Tsao K. C. Sun C. F. Wu J. T. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta: 2003; 327 (1-2): 95 101
63. Rainer T. H. Lam N. Y. Man C. Y. Chiu R. W. Woo K. S. Lo Y. M. Plasma beta-globin DNA as a prognostic marker in chest pain patients. Clin Chim Acta: 2006; 368 (1-2): 110 113
64. Antonatos D. Patsilinakos S. Spanodimos S. Korkonikitas P. Tsigas D. Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci: 2006; 1075 278 281
65. Shimony A. Zahger D. Gilutz H., et al. Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care: 2010; 12 03 109 111
66. Destouni A. Vrettou C. Antonatos D., et al. Cell-free DNA levels in acute myocardial infarction patients during hospitalization. Acta Cardiol: 2009; 64 01 51 57
67. Wang L. Xie L. Zhang Q., et al. Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients. Coron Artery Dis: 2015; 26 04 296 300
68. Bliksoen M. Mariero L. H. Ohm I. K., et al. Increased circulating mitochondrial DNA after myocardial infarction. Int J Cardiol: 2012; 158 01 132 134
69. Jing R. R. Wang H. M. Cui M., et al. A sensitive method to quantify human cell-free circulating DNA in blood: relevance to myocardial infarction screening. Clin Biochem: 2011; 44 13 1074 1079
70. Kumar A. Cannon C. P. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc: 2009; 84 10 917 938
71. Cui M. Fan M. Jing R., et al. Cell-free circulating DNA: a new biomarker for the acute coronary syndrome. Cardiology: 2013; 124 02 76 84
72. Veinot J. P. Gattinger D. A. Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol: 1997; 28 04 485 492
73. Brickner M. E. Hillis L. D. Lange R. A. Congenital heart disease in adults. First of two parts. N Engl J Med: 2000; 342 04 256 263
74. Dick S. A. Epelman S. Chronic heart failure and inflammation: what do we really know? Circ Res: 2016; 119 01 159 176
75. Nymo S. H. Ueland T. Askevold E., et al. Circulating nucleosomes in chronic heart failure. Int J Cardiol: 2016; 203 742 743
76. Dhondup Y. Ueland T. Dahl C. P., et al. Low circulating levels of mitochondrial and high levels of nuclear DNA predict mortality in chronic heart failure. J Card Fail: 2016; 22 10 823 828
77. Rainer T. H. Wong L. K. Lam W., et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem: 2003; 49 04 562 569
78. Lam N. Y-L. Rainer T. H. Wong L. K-S. Lam W. Lo Y. M. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. Resuscitation: 2006; 68 01 71 78
79. Geiger S. Holdenrieder S. Stieber P., et al. Nucleosomes in serum of patients with early cerebral stroke. Cerebrovasc Dis: 2006; 21 (1-2): 32 37
80. Mahoney F. I. Barthel D. W. Functional evaluation: the Barthel index. Md State Med J: 1965; 14 61 65
81. Geiger S. Holdenrieder S. Stieber P., et al. Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol: 2007; 254 05 617 623
82. Tsai N-W. Lin T-K. Chen S-D., et al. The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin Chim Acta: 2011; 412 (5-6): 476 479
83. Brott T. Adams H. P. Jr. Olinger C. P., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke: 1989; 20 07 864 870
84. Hirose T. Hamaguchi S. Matsumoto N., et al. Presence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients. PLoS One: 2014; 9 11 e111755
85. Thålin C. Demers M. Blomgren B., et al. NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation. Thromb Res: 2016; 139 56 64
86. Lusis A. J. Atherosclerosis. Nature: 2000; 407 (6801): 233 241
87. Gannushkina I. V. Farago M. L. Karpukhin A. V., et al. Plasma DNA levels in patients with atherosclerotic involvement of the major arteries of the head and lateral amyotrophic sclerosis. Bull Exp Biol Med: 1997; 124 12 610 612
88. Borissoff J. I. Joosen I. A. Versteylen M. O., et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol: 2013; 33 08 2032 2040
89. Qian Q. Thrombotic microangiopathy not associated with the classic/idiopathic TTP-HUS. In: Fervenza F. C. Lin J. Sethi S. Singh A. K., eds. Core Concepts in Parenchymal Kidney Disease. New York, NY Springer: 2014; 249 262
90. Fuchs T. A. Kremer Hovinga J. A. Schatzberg D. Wagner D. D. Lämmle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood: 2012; 120 06 1157 1164
91. Ramos M. V. Mejias M. P. Sabbione F., et al. Induction of neutrophil extracellular traps in Shiga toxin-associated hemolytic uremic syndrome. J Innate Immun: 2016; 8 04 400 411
92. Laskin B. L. Goebel J. Davies S. M. Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood: 2011; 118 06 1452 1462
93. Arai Y. Yamashita K. Mizugishi K., et al. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant: 2013; 19 12 1683 1689
94. Liaw P. C. Ito T. Iba T., et al. DAMP and DIC: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. Blood Rev: 2016; 30 04 257 261
95. Nakahara M. Ito T. Kawahara K., et al. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS One: 2013; 8 09 e75961
96. Taylor F. B. Jr. Toh C. H. Hoots W. K. Wada H. Levi M.; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost: 2001; 86 05 1327 1330
97. Kim J. E. Lee N. Gu J. Y. Yoo H. J. Kim H. K. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation. Thromb Res: 2015; 135 06 1064 1069
98. Dicke C. Amirkhosravi A. Spath B., et al. Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study. Exp Hematol Oncol: 2015; 4 22
99. Park H. S. Gu J. You H. J. Kim J. E. Kim H. K. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation. Thromb Res: 2016; 138 103 107
100. Hill A. Kelly R. J. Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood: 2013; 121 25 4985 4996, quiz 5105
101. van Bijnen S. T. Wouters D. van Mierlo G. J. Muus P. Zeerleder S. Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab. J Thromb Haemost: 2015; 13 11 2004 2011
102. Ortel T. L. Thrombosis and the antiphospholipid syndrome. Hematology (Am Soc Hematol Educ Program): 2005; ••• 462 468
103. Yalavarthi S. Gould T. J. Rao A. N., et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol: 2015; 67 11 2990 3003
104. Herrera L. J. Raja S. Gooding W. E., et al. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem: 2005; 51 01 113 118
105. Bardoel B. W. Kenny E. F. Sollberger G. Zychlinsky A. The balancing act of neutrophils. Cell Host Microbe: 2014; 15 05 526 536
106. Demers M. Wagner D. D. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost: 2014; 40 03 277 283
107. Liu J. Zou Y. Tang Y., et al. Circulating cell-free mitochondrial deoxyribonucleic acid is increased in coronary heart disease patients with diabetes mellitus. J Diabetes Investig: 2016; 7 01 109 114
108. Veneri D. Franchini M. Randon F. Nichele I. Pizzolo G. Ambrosetti A. Thrombocytopenias: a clinical point of view. Blood Transfus: 2009; 7 02 75 85
109. Kleinegris M. C. ten Cate H. ten Cate-Hoek A. J. D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review. Thromb Haemost: 2013; 110 02 233 243
110. Kannemeier C. Shibamiya A. Nakazawa F., et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A: 2007; 104 15 6388 6393
111. Labberton L. Kenne E. Long A. T., et al. Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection. Nat Commun: 2016; 7 12616